The role of AI in proteomics
23 May 2024
Parag Mallick, Associate Professor at Stanford University and CoFounder and Chief Scientist at Nautilus Biotechnology, explores the transformative impact of artificial intelligence on proteomics. He discusses the significance of proteomics in life sciences and drug discovery, highlighting how machine learning at Nautilus enhances the analysis of complex protein data, surpassing traditional methods. Mallick also discusses the challenges of handling vast protein datasets and shares strategies for overcoming these hurdles. Additionally, he offers his vision for the future of proteomics in healthcare and draws intriguing parallels between his work in proteomics and his passion for magic, revealing how these interests uniquely complement each other.
About the company
Nautilus Biotechnology
Nautilus Biotechnology was founded in 2016 on the belief that incremental advancements to existing technologies are inadequate; that a bold scientific leap is required to radically reinvent proteomics and create a new gold standard in the field. Nautilus exists to pursue deep, hard science and, ultimately, to positively impact the health of millions around the world.